Axogen Inc Cmn (AXGN) 8.99 $AXGN Your Complete Guide to

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Axogen Inc Cmn (AXGN) 8.99 $AXGN

Your Complete Guide to the Generic Drug Industry
Ryan McQueeney - Zacks Investment Research - Mon Aug 29, 4:13PM CDT
Today we'll take a look at how generics are developed and how they affect the drug industry today.
AGN: 237.76 (+3.22), GNRX: 24.40 (-0.14), PRGO: 91.25 (+0.26), AXGN: 8.99 (-0.02), AKRX: 26.68 (-0.24), MYL: 41.92 (-0.44), TEVA: 50.90 (+0.51), AMPH: 18.99 (-0.01), NVS: 78.27 (-0.50)

AxoGen, Inc. to Present at Wedbush PacGrow Healthcare Conference 2016
GlobeNewswire - Thu Aug 11, 6:00AM CDT
AxoGen, Inc. (NASDAQ:AXGN), a global leader in innovative surgical solutions for peripheral nerve injuries, today announced that Karen Zaderej, President and Chief Executive Officer, will present at the Wedbush PacGrow Healthcare Conference 2016 in New York City at Le Parker Meridien Hotel. The presentation is scheduled for Wednesday, August 17, 2016 at 9:10 am ET (6:10 am PT).
AXGN: 8.99 (-0.02)

AxoGen, Inc. Reports Financial Results for Second Quarter 2016
GlobeNewswire - Wed Aug 03, 3:20PM CDT
AxoGen, Inc. (NASDAQ:AXGN), a global leader in innovative surgical solutions for peripheral nerve injuries, today announced financial results for the second quarter ended June 30, 2016 and provided a business update.
AXGN: 8.99 (-0.02)

AxoGen, Inc.'s Avance(R) Nerve Graft Data to be Presented at 2016 Federation of European Societies for Surgery of the Hand International Congress
GlobeNewswire - Tue Jun 21, 6:00AM CDT
AxoGen, Inc. (NASDAQ:AXGN), a leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the acceptance of four presentations at the Congress of the Federation of European Societies for Surgery of the Hand (FESSH) related to use of Avance(R) Nerve Graft, including data from the RANGER(R) Registry. The data to be presented highlights that sensory and motor recovery outcomes from Avance(R) Nerve Graft repairs, in this group of patients, were found to compare favorably with autograft (nerve transplanted from the patient's own body). The data contained mixed nerve injuries up to 70 mm repaired with either Avance(R) Nerve Graft or autograft and both reported outcomes with greater than 85% meaningful recovery.
AXGN: 8.99 (-0.02)

AxoGen, Inc. First Quarter Revenue Increases 64% Over Prior Year to $8.1 Million
GlobeNewswire - Wed May 04, 3:10PM CDT
AxoGen, Inc. (NASDAQ:AXGN), a leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results for the first quarter ended March 31, 2016 and recent corporate developments.
AXGN: 8.99 (-0.02)

AxoGen (AXGN) Enters Overbought Territory
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 8:52AM CDT
AxoGen, Inc. (AXGN) has moved higher as of late, but there could definitely be trouble on the horizon for this company
AXGN: 8.99 (-0.02)

AxoGen, Inc. to Feature Nerve Repair Solutions at the American College of Oral and Maxillofacial Surgeons (ACOMS) Annual Scientific Conference and Exhibition
GlobeNewswire - Fri Apr 08, 5:59AM CDT
via PRWEB - AxoGen, Inc. (NASDAQ: AXGN), a leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced its participation in the 2016 American College of Oral and Maxillofacial Surgeons (ACOMS) Annual Scientific Conference and Exhibition taking place in San Juan, Puerto Rico from April 9-12, 2016.
AXGN: 8.99 (-0.02)

AxoGen, Inc. Launches AcroVal™ Neurosensory & Motor Testing System
PRWeb - Wed Mar 30, 6:07AM CDT
AxoGen, Inc. (NASDAQ: AXGN), a leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the commercial release and first sale of AcroVal™ Neurosensory & Motor Testing System (NSMTS), a nerve function evaluation solution for surgeons and other allied health professionals to electronically measure, map, and monitor patients with peripheral nerve injuries and conditions. AcroVal™ is the Company's latest product introduction and will be complementary to the Company's portfolio of nerve repair products - Avance(R) Nerve Graft, AxoGuard(R) Nerve Connector and AxoGuard(R) Nerve Protector.
AXGN: 8.99 (-0.02)

AxoGen, Inc. Launches AcroVal(TM) Neurosensory & Motor Testing System
GlobeNewswire - Wed Mar 30, 6:05AM CDT
via PRWEB - AxoGen, Inc. (NASDAQ: AXGN), a leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the commercial release and first sale of AcroVal(TM) Neurosensory & Motor Testing System (NSMTS), a nerve function evaluation solution for surgeons and other allied health professionals to electronically measure, map, and monitor patients with peripheral nerve injuries and conditions. AcroVal(TM) is the Company's latest product introduction and will be complementary to the Company's portfolio of nerve repair products - Avance(R) Nerve Graft, AxoGuard(R) Nerve Connector and AxoGuard(R) Nerve Protector.
AXGN: 8.99 (-0.02)

AxoGen, Inc. to Report Fourth Quarter and Full Year Results on February 29, 2016
PRWeb - Wed Feb 10, 6:04AM CST
AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral nerve repair market, will report results for the fourth quarter and full year ended December 31, 2015 on Monday, February 29, 2016 after the market closes.
AXGN: 8.99 (-0.02)

AxoGen, Inc. Avance(R) Nerve Graft Recipient to be Honored on Donate Life Rose Parade Float
PRWeb - Mon Dec 28, 3:31PM CST
AxoGen, Inc. (NASDAQ: AXGN), a leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced that Matthew Jayroe, one of the thousands of patients who have had injured nerves repaired with AxoGen's Avance(R) Nerve Graft, will be honored as a recipient of donated nerve tissue.
AXGN: 8.99 (-0.02)

Equity Market Movement at a Glance - Research on AxoGen, Ampio Pharmaceuticals, Ultra Clean Holdings and Willbros Group
ACCESSWIRE - Mon Nov 23, 6:50AM CST
NEW YORK, NY / ACCESSWIRE / November 23, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: AxoGen Inc. (NASDAQ: AXGN), Ampio Pharmaceuticals Inc. (NYSE: AMPE), Ultra Clean Holdings Inc. (NASDAQ: UCTT) and Willbros Group Inc. (NYSE: WG). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
AXGN: 8.99 (-0.02), WG: 1.89 (-0.05), AMPE: 0.86 (+0.03), UCTT: 7.36 (+0.09)

AxoGen Inc. Third Quarter Revenue Exceeds $8 Million
GlobeNewswire - Thu Nov 05, 3:17PM CST
via PRWEB - AxoGen, Inc. (NASDAQ: AXGN), a leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, reported record revenue of $8.15 million in the third quarter. The record quarterly result represents the first time in the Company's history that quarterly revenue surpassed $8 million. In addition, management raised revenue guidance for the full year to reflect the strong year-to-date growth.
AXGN: 8.99 (-0.02)

PDL BioPharma Announces Third Quarter 2015 Financial Results
PR Newswire - Wed Nov 04, 3:03PM CST
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the third quarter and nine months ended September 30, 2015.
ACRX: 3.05 (-0.10), AXGN: 8.99 (-0.02), DEPO: 20.60 (+0.31), ARIA: 10.19 (-0.15), PDLI: 2.97 (+0.06)

Leading 200 Global Medical Devices/Technology/Supplies Companies that have Launched New Products
M2 - Thu Oct 22, 2:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qrcc44/global_new) has announced the addition of the "Global New Products Medical Devices/Technology/Supplies 200 " report to their offering. The newly launched report identifies 200 medical devices/technology/supplies companies globally that have launched New Products recently, and covers news of such 200 companies as well as provides details about new products launched by these companies. Medical scientists and physicians are constantly conducting research and testing new procedures to help prevent, diagnose, and cure diseases as well as developing new drugs and new medical products/devices/technology that can lessen symptoms or treat ailments. Profound insight into the companies' value drivers of innovation can release additional, untapped potential. From small innovations like adhesive bandages and ankle braces, to larger, more complex technologies like MRI machines, artificial organs, and robotic prosthetic limbs, technology has undoubtedly made an incredible impact on medicine. Highlights - Leading 200 global medical devices/technology/supplies companies that have launched new products recently covered - Provides detailed summary on new product categories - Summary of other news besides product launch for such companies - Important M&A and alliances of global medical devices/technology/supplies companies with new products - International presence of global medical devices/technology/supplies companies with new products Key Topics Covered: 1: Key New Products Launched by Global Medical Devices/Technology/Supplies Companies 2: Analysis of Global Medical Devices/Technology/Supplies Companies with New Products by Various Attributes 3: Key News of Global Medical Devices/Technology/Supplies Companies with New Products for Year 2014-15 4: Key Alliances of Global Medical Devices/Technology/Supplies Companies with New Products 5: International Presence of Global Medical Devices/Technology/Supplies Companies with New Products 6: Mergers and Acquisitions of Global Medical Devices/Technology/Supplies Companies with New Products Companies Mentioned - Partial List - 3D Systems Corporation - Accuray Inc - Acelity L.P. Inc - Affymetrix, Inc. - Aurora Spine Corp - Avita Medical Limited - AxoGen Inc. - Calgary Scientific Inc. - Cardica, Inc - Cardiocomm Solutions? - Carl Zeiss Meditec AG - Cellavision AB - CloudTag Inc - Cochlear Limited - Cogentix Medical Inc. - Coherent Incorporated - Electromed, Incorporation - Elekta publ AB - Encision Inc - Endologix, Inc. - Entellus Medical Inc - Exactech, Inc. - Exiqon AS - FEI Company - Fisher & Paykel Healthcare Corporation Limited - Fluidigm Corp. - Foundation Medicine Inc. - Fresenius Medical Care AG & Co. KGaA For more information visit http://www.researchandmarkets.com/research/qrcc44/global_new
AXGN: 8.99 (-0.02), DDD: 14.21 (-0.29), ARAY: 5.30 (-0.03), ELGX: 12.22 (+0.06), AFFX: 14.01 (+0.02), FEIC: 106.56 (+0.09), CGNT: 1.16 (-0.09), FMI: 20.63 (+0.11), FLDM: 8.79 (-0.32), ENTL: 18.76 (-0.13), CRDC: 2.35 (-0.15), EXAC: 27.80 (+0.01), COHR: 106.11 (+0.93)

AxoGen, Inc. to Report Third Quarter Results on November 5, 2015
GlobeNewswire - Fri Oct 16, 6:04AM CDT
via PRWEB - AxoGen, Inc. (NASDAQ:AXGN), a leading medical technology company focused on the peripheral nerve repair market, will report results for the third quarter and nine months ended September 30, 2015 on Thursday, November 5, 2015 after the market closes.
AXGN: 8.99 (-0.02)

AxoGen, Inc. to Present at the Dawson James Securities Small Cap Growth Conference
GlobeNewswire - Thu Oct 08, 6:06AM CDT
via PRWEB - AxoGen, Inc. (NASDAQ:AXGN), a leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, is scheduled to present at the Dawson James Securities 2015 Small Cap Growth Stock Conference on Thursday, October 15, 2015 at 8:30am ET at the Wyndham Grand Jupiter at Harbourside Place in Jupiter, Florida.
AXGN: 8.99 (-0.02)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mercari and Suruga-ya Forge U.S. Venture for Culture

Updated Category News Views 0

Japanese Pop Culture Gears Up for US Market Surge Alright, folks, what we’ve got here is another bold move in the cross-border e-commerce game. Mercari and Suruga-ya are teaming up to establish a joint venture over in the U.S. The goal? To further capitalize on the growing appetite for Japanese entertainment and hobby goods among us all stateside. Now, it’s no secret...

Continue Reading
Tuya Smart: AI Powers New Energy Wave at COP31

Updated Category News Views 55

Tuya Smart's Bold Move at COP31 Tuya Smart, a name you don't want to ignore in the world of energy innovation, made a commanding appearance at COP31. Their message was loud and clear: as the climate gets harsher, they're not just sitting around waiting for the next storm. They're arming households with AI-driven solutions. AI-Powered Energy Management Takes Center Stage...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 229

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 64

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 275

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Hanwha Power Seals Second FSRU Conversion Deal

Updated Category News Views 71

Riding the FSRU Wave with Hanwha Power Alright, we've got Hanwha Power step-dancing onto the LNG stage with its second splash into the FSRU (Floating Storage and Regasification Unit) conversion gig. Partnering up with Energos Infrastructure, these guys are making serious waves in the energy market by transforming what's pretty much a regular ship into a floating gas...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 218

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 175

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 407

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 178

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading

Top 5 Most Recently Viewed Articles

Balavant Insurance Group Welcomes John Jankowski as CIO

Updated Category News Views 317

Leadership Appointment at Balavant Insurance Group Balavant Insurance Group has made a significant move by appointing John Jankowski as its new Chief Information Officer. This announcement marks a pivotal moment for the company, known for its focus on technological advancement and innovative insurance solutions. Strategic Role of the Chief Information Officer In his role,...

Continue Reading
Exploring the Growth of the Industrial Absorbent Sector

Updated Category News Views 245

Understanding the Industrial Absorbent Market Dynamics The industrial absorbent market is poised for remarkable growth, expected to reach $5.50 billion by 2031. This growth trajectory aligns with a compound annual growth rate (CAGR) of 4.3%. The increase in market size is largely driven by the rising usage of absorbents across various industries in response to...

Continue Reading
ChoiceOne Financial Services Achieves Successful Bank Merger

Updated Category News Views 147

Successful Bank Merger by ChoiceOne Financial Services ChoiceOne Financial Services, Inc. (NASDAQ: COFS), the parent company of ChoiceOne Bank, has achieved a significant milestone by completing the consolidation of The State Bank into ChoiceOne Bank. This strategic move empowers the strength of ChoiceOne, further enhancing its service capabilities and market presence. A...

Continue Reading
Danantara Indonesia and INA Forge Nickel Investment Alliance with Eramet

Updated Category News Views 443

Strategic Collaboration for Nickel Development In a significant move to bolster the nickel downstream industry, partners including Danantara Indonesia and the Indonesia Investment Authority (INA) have officially signed a Memorandum of Understanding (MoU) with the prominent French mining company, Eramet. This collaboration aims to create an extensive investment platform...

Continue Reading
Full Moon Bar-B-Que's Generous Initiative for Local Kids

Updated Category News Views 180

Full Moon Bar-B-Que's Generosity In a heartwarming gesture, Full Moon Bar-B-Que has made a significant impact on the community by contributing $200,000 worth of backpacks and school supplies. Their ongoing commitment through the Backpack Blessings program is not just about donations; it's about nurturing and empowering local children who need support the most. Supporting...

Continue Reading